Loading...

Lau, Wei Ling

TitleAssistant Health Sciences Professor
InstitutionUniversity of California, Irvine
DepartmentMedicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Lau WL, Vaziri ND, Nunes AC, Comeau AM, Langille MG, England W, Khazaeli M, Suematsu Y, Phan J, Whiteson K. The phosphate binder ferric citrate alters the gut microbiome in rats with chronic kidney disease. J Pharmacol Exp Ther. 2018 Oct 04. PMID: 30287477.
      View in: PubMed
    2. Jing W, Nunes A, Farzaneh T, Khazaeli M, Lau WL, Vaziri ND. Phosphate binder, ferric citrate, attenuates anemia, renal dysfunction, oxidative stress, inflammation and fibrosis in 5/6 nephrectomized CKD rats. J Pharmacol Exp Ther. 2018 Aug 09. PMID: 30093458.
      View in: PubMed
    3. Lau WL, Lin HY, Wang PH. Urine mitochondrial DNA and diabetic nephropathy-a new frontier. Nephrol Dial Transplant. 2018 May 01; 33(5):719-721. PMID: 29401284.
      View in: PubMed
    4. Lau WL, Obi Y, Kalantar-Zadeh K. Parathyroidectomy in the Management of Secondary Hyperparathyroidism. Clin J Am Soc Nephrol. 2018 Mar 09. PMID: 29523679.
      View in: PubMed
    5. Lau WL, Savoj J, Nakata MB, Vaziri ND. Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins. Clin Sci (Lond). 2018 Mar 15; 132(5):509-522. PMID: 29523750.
      View in: PubMed
    6. Lau WL, Khazaeli M, Savoj J, Manekia K, Bangash M, Thakurta RG, Dang A, Vaziri ND, Singh B. Dietary tetrahydrocurcumin reduces renal fibrosis and cardiac hypertrophy in 5/6 nephrectomized rats. Pharmacol Res Perspect. 2018 Apr; 6(2):e00385. PMID: 29468071.
      View in: PubMed
    7. Yu JZ, Rhee CM, Ferrey A, Li A, Jin A, Chang Y, Reddy U, Lau WL, Chou J, Inrig J, Kalantar-Zadeh K. There's no place like home: 35-year patient survival on home hemodialysis. Semin Dial. 2018 May; 31(3):300-304. PMID: 29265477.
      View in: PubMed
    8. Obi Y, Streja E, Mehrotra R, Rivara MB, Rhee CM, Soohoo M, Gillen DL, Lau WL, Kovesdy CP, Kalantar-Zadeh K. Impact of Obesity on Modality Longevity, Residual Kidney Function, Peritonitis, and Survival Among Incident Peritoneal Dialysis Patients. Am J Kidney Dis. 2017 Dec 06. PMID: 29223620.
      View in: PubMed
    9. Lau WL, Vaziri ND. The Leaky Gut and Altered Microbiome in Chronic Kidney Disease. J Ren Nutr. 2017 Nov; 27(6):458-461. PMID: 29056165.
      View in: PubMed
    10. Lin MC, Streja E, Soohoo M, Hanna M, Savoj J, Kalantar-Zadeh K, Lau WL. Warfarin Use and Increased Mortality in End-Stage Renal Disease. Am J Nephrol. 2017; 46(4):249-256. PMID: 28910806.
      View in: PubMed
    11. Wang M, Obi Y, Streja E, Rhee CM, Lau WL, Chen J, Hao C, Hamano T, Kovesdy CP, Kalantar-Zadeh K. Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function. Clin J Am Soc Nephrol. 2017 Jul 07; 12(7):1118-1127. PMID: 28487345.
      View in: PubMed
    12. Ghahremani-Ghajar M, Rojas-Bautista V, Lau WL, Pahl M, Hernandez M, Jin A, Reddy U, Chou J, Obi Y, Kalantar-Zadeh K, Rhee CM. Incremental Hemodialysis: The University of California Irvine Experience. Semin Dial. 2017 05; 30(3):262-269. PMID: 28295607.
      View in: PubMed
    13. Chang Y, Lau WL, Jo H, Tsujino K, Gewin L, Reed NI, Atakilit A, Nunes ACF, DeGrado WF, Sheppard D. Pharmacologic Blockade of avß1 Integrin Ameliorates Renal Failure and Fibrosis In Vivo. J Am Soc Nephrol. 2017 Jul; 28(7):1998-2005. PMID: 28220032.
      View in: PubMed
    14. Lau WL, Vaziri ND. Urea, a true uremic toxin: the empire strikes back. Clin Sci (Lond). 2017 Jan 01; 131(1):3-12. PMID: 27872172.
      View in: PubMed
    15. Ferrey A, Fujitani RM, Tran MH, Chang Y, Lau WL. Successful Peritoneal Dialysis Catheter Placement in a New End-Stage Renal Disease Patient with Combined Antiphospholipid Syndrome and Factor XI Deficiency. Adv Perit Dial. 2017 Jan; 33(2017):22-25. PMID: 29668426.
      View in: PubMed
    16. Obi Y, Nguyen DV, Streja E, Rivara MB, Rhee CM, Lau WL, Chen Y, Kovesdy CP, Mehrotra R, Kalantar-Zadeh K. Development and Validation of a Novel Laboratory-Specific Correction Equation for Total Serum Calcium and Its Association With Mortality Among Hemodialysis Patients. J Bone Miner Res. 2017 Mar; 32(3):549-559. PMID: 27714897.
      View in: PubMed
    17. Vaziri ND, Khazaeli M, Nunes ACF, Harley KT, Said H, Alipour O, Lau WL, Pahl MV. Effects of end-stage renal disease and dialysis modalities on blood ammonia level. Hemodial Int. 2017 07; 21(3):343-347. PMID: 27804262.
      View in: PubMed
    18. Wang M, Chou J, Chang Y, Lau WL, Reddy U, Rhee CM, Chen J, Hao C, Kalantar-Zadeh K. The role of low protein diet in ameliorating proteinuria and deferring dialysis initiation: what is old and what is new. Panminerva Med. 2017 Jun; 59(2):157-165. PMID: 27759735.
      View in: PubMed
    19. Lau WL, Huisa BN, Fisher M. The Cerebrovascular-Chronic Kidney Disease Connection: Perspectives and Mechanisms. Transl Stroke Res. 2017 02; 8(1):67-76. PMID: 27628245.
      View in: PubMed
    20. Obi Y, Mehrotra R, Rivara MB, Streja E, Rhee CM, Lau WL, Kovesdy CP, Kalantar-Zadeh K. Hidden Hypercalcemia and Mortality Risk in Incident Hemodialysis Patients. J Clin Endocrinol Metab. 2016 06; 101(6):2440-9. PMID: 27045726.
      View in: PubMed
    21. Soohoo M, Feng M, Obi Y, Streja E, Rhee CM, Lau WL, Wang J, Ravel VA, Brunelli S, Kovesdy CP, Kalantar-Zadeh K. Changes in Markers of Mineral and Bone Disorders and Mortality in Incident Hemodialysis Patients. Am J Nephrol. 2016; 43(2):85-96. PMID: 26950688.
      View in: PubMed
    22. Doshi M, Streja E, Rhee CM, Park J, Ravel VA, Soohoo M, Moradi H, Lau WL, Mehrotra R, Kuttykrishnan S, Kovesdy CP, Kalantar-Zadeh K, Chen JL. Examining the robustness of the obesity paradox in maintenance hemodialysis patients: a marginal structural model analysis. Nephrol Dial Transplant. 2016 08; 31(8):1310-9. PMID: 26590266; PMCID: PMC4967726 [Available on 08/01/17].
    23. Lau WL, Kalantar-Zadeh K. Why Is the Association of Phosphorus and FGF23 with Mortality Stronger in African-American Hemodialysis Patients. Am J Nephrol. 2015; 42(1):22-4. PMID: 26288017.
      View in: PubMed
    24. Lau WL, Kalantar-Zadeh K, Vaziri ND. The Gut as a Source of Inflammation in Chronic Kidney Disease. Nephron. 2015; 130(2):92-8. PMID: 25967288; PMCID: PMC4485546.
    25. Kalantar-Zadeh K, Tortorici AR, Chen JL, Kamgar M, Lau WL, Moradi H, Rhee CM, Streja E, Kovesdy CP. Dietary restrictions in dialysis patients: is there anything left to eat? Semin Dial. 2015 Mar-Apr; 28(2):159-68. PMID: 25649719; PMCID: PMC4385746.
    26. Vaziri ND, Liu SM, Lau WL, Khazaeli M, Nazertehrani S, Farzaneh SH, Kieffer DA, Adams SH, Martin RJ. High amylose resistant starch diet ameliorates oxidative stress, inflammation, and progression of chronic kidney disease. PLoS One. 2014; 9(12):e114881. PMID: 25490712; PMCID: PMC4260945.
    27. Lau WL, Liu SM, Pahlevan S, Yuan J, Khazaeli M, Ni Z, Chan JY, Vaziri ND. Role of Nrf2 dysfunction in uremia-associated intestinal inflammation and epithelial barrier disruption. Dig Dis Sci. 2015 May; 60(5):1215-22. PMID: 25399330.
      View in: PubMed
    28. Henke PK, Zamora-Berridi G, Englesbe MJ, Cai S, Brooks L, McKeown E, Phillips L, Lau W, Campbell DC. A case-cohort study of postoperative myocardial infarction: impact of anemia and cardioprotective medications. Surgery. 2014 Oct; 156(4):1018-26, 1029. PMID: 25239363.
      View in: PubMed
    29. Lau WL, Liu S, Vaziri ND. Chronic kidney disease results in deficiency of ABCC6, the novel inhibitor of vascular calcification. Am J Nephrol. 2014; 40(1):51-5. PMID: 24994603.
      View in: PubMed
    30. Lau WL, Kalantar-Zadeh K. Towards the revival of alkaline phosphatase for the management of bone disease, mortality and hip fractures. Nephrol Dial Transplant. 2014 Aug; 29(8):1450-2. PMID: 24737443; PMCID: PMC4106643.
    31. Rhee CM, Lertdumrongluk P, Streja E, Park J, Moradi H, Lau WL, Norris KC, Nissenson AR, Amin AN, Kovesdy CP, Kalantar-Zadeh K. Impact of age, race and ethnicity on dialysis patient survival and kidney transplantation disparities. Am J Nephrol. 2014; 39(3):183-94. PMID: 24556752; PMCID: PMC4024458.
    32. Streja E, Wang HY, Lau WL, Molnar MZ, Kovesdy CP, Kalantar-Zadeh K, Park J. Mortality of combined serum phosphorus and parathyroid hormone concentrations and their changes over time in hemodialysis patients. Bone. 2014 Apr; 61:201-7. PMID: 24486956; PMCID: PMC4024455.
    33. Li L, Lau WL, Rhee CM, Harley K, Kovesdy CP, Sim JJ, Jacobsen S, Chang A, Landman J, Kalantar-Zadeh K. Risk of chronic kidney disease after cancer nephrectomy. Nat Rev Nephrol. 2014 Mar; 10(3):135-45. PMID: 24419566.
      View in: PubMed
    34. Rhee CM, Molnar MZ, Lau WL, Ravel V, Kovesdy CP, Mehrotra R, Kalantar-Zadeh K. Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis. Perit Dial Int. 2014 Nov-Dec; 34(7):732-48. PMID: 24385335; PMCID: PMC4269499.
    35. Streja E, Lau WL, Goldstein L, Sim JJ, Molnar MZ, Nissenson AR, Kovesdy CP, Kalantar-Zadeh K. Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients. Kidney Int Suppl (2011). 2013 Dec; 3(5):462-468. PMID: 25019031.
      View in: PubMed
    36. Lertdumrongluk P, Rhee CM, Park J, Lau WL, Moradi H, Jing J, Molnar MZ, Brunelli SM, Nissenson AR, Kovesdy CP, Kalantar-Zadeh K. Association of serum phosphorus concentration with mortality in elderly and nonelderly hemodialysis patients. J Ren Nutr. 2013 Nov; 23(6):411-21. PMID: 23631888; PMCID: PMC3735629.